AGTR2 and cardiac hypertrophy: Similarly, Ang 1-7 administration prevents cardiac remodeling in Ang II treated rats without modifying AT1 and AT2 receptor population [20], and attenuates myocardial hypertrophy by a mitochondrial ROS-dependent mechanism [21].